Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MGTA

Magenta Therapeutics

$18.77

0.805 (4.48%)

05:11
03/25/19
03/25
05:11
03/25/19
05:11
Downgrade
Magenta Therapeutics rating change at Goldman Sachs »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Sunday
MGTA

Magenta Therapeutics

$18.77

0.805 (4.48%)

19:21
03/24/19
03/24
19:21
03/24/19
19:21
Downgrade
Magenta Therapeutics rating change at Goldman Sachs »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
MGTA

Magenta Therapeutics

$18.66

1.27 (7.30%)

07:37
03/19/19
03/19
07:37
03/19/19
07:37
Hot Stocks
Magenta Therapeutics declared development candidate in C200 program »

At the end of 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGTA

Magenta Therapeutics

$18.66

1.27 (7.30%)

07:37
03/19/19
03/19
07:37
03/19/19
07:37
Hot Stocks
Magenta Therapeutics to declare development candidate for C100 program in 2019 »

At the Transplant and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGTA

Magenta Therapeutics

$18.66

1.27 (7.30%)

07:35
03/19/19
03/19
07:35
03/19/19
07:35
Hot Stocks
Magenta Therapeutics plans to begin Phase 1 study of MGTA-145 agent in 2019 »

The company plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGTA

Magenta Therapeutics

$18.66

1.27 (7.30%)

07:33
03/19/19
03/19
07:33
03/19/19
07:33
Hot Stocks
Magenta Therapeutics sees cash, cash equivalents 'sufficient' through 2020 »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGTA

Magenta Therapeutics

$18.66

1.27 (7.30%)

07:32
03/19/19
03/19
07:32
03/19/19
07:32
Earnings
Magenta Therapeutics reports Q4 EPS (50c), consensus (56c) »

"2018 was a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGTA

Magenta Therapeutics

$13.64

-0.58 (-4.08%)

17:22
03/14/19
03/14
17:22
03/14/19
17:22
Initiation
Magenta Therapeutics initiated at Raymond James »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MGTA

Magenta Therapeutics

$9.30

0.66 (7.64%)

08:25
02/25/19
02/25
08:25
02/25/19
08:25
Hot Stocks
Magenta Therapeutics presents data on MGTA-456 cell therapy »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTA

Magenta Therapeutics

$9.30

0.66 (7.64%)

08:20
02/25/19
02/25
08:20
02/25/19
08:20
Hot Stocks
Magenta Therapeutics presents preclinical data on targeted conditioning programs »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.